Intervention Review

Cannabinoid type 1 receptor antagonists for smoking cessation

  1. Kate Cahill1,*,
  2. Michael H Ussher2

Editorial Group: Cochrane Tobacco Addiction Group

Published Online: 16 MAR 2011

Assessed as up-to-date: 24 JAN 2011

DOI: 10.1002/14651858.CD005353.pub4

How to Cite

Cahill K, Ussher MH. Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD005353. DOI: 10.1002/14651858.CD005353.pub4.

Author Information

  1. 1

    University of Oxford, Department of Primary Health Care, Oxford, UK

  2. 2

    St George's, University of London, Division of Population Health Sciences and Education, London, UK

*Kate Cahill, Department of Primary Health Care, University of Oxford, Rosemary Rue Building, Old Road Campus, Oxford, OX3 7LF, UK. kate.cahill@dphpc.ox.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 16 MAR 2011

SEARCH

  1. Current Version

    Cannabinoid type 1 receptor antagonists for smoking cessation

    Kate Cahill and Michael H Ussher

    Article first published online: 16 MAR 2011 | DOI: 10.1002/14651858.CD005353.pub4

Previous versions of this article and their online publication dates

  1. Version 3

    Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

    Kate Cahill and Michael H Ussher

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD005353.pub3

  2. Version 2

    Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

    K Cahill and M Ussher

    Article first published online: 18 JUL 2007 | DOI: 10.1002/14651858.CD005353.pub2

  3. Version 1

    Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation

    K Hey, MH Ussher and T Lancaster

    Article first published online: 18 APR 2007 | DOI: 10.1002/14651858.CD005353